Fidelity Management & Research has led a $325m series B round for Biontech, a spinout of Johannes Gutenberg University Mainz whose backers also include Sanofi and Pfizer.
Biontech, a Germany-based immuno-oncology therapy developer spun out of Johannes Gutenberg University Mainz, closed a $325m series B round yesterday led by financial services group Fidelity Management & Research.
Redmile Group, Invus, MiraeAsset Financial Group, Platinum Asset Management, Jebsen Capital, Steam Athena Capital, BVCF Management and the Struengmann Family Office as well as unnamed new and existing investors took part in the round.
Biontech previously obtained $91.5m in equity funding from pharmaceutical firm Sanofi as part of…
Thierry Heles
Thierry Heles is editor-at-large of Global University Venturing and Global Corporate Venturing, and host of the Beyond the Breakthrough podcast.
